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We have studied 322 patients, 80 years of age or older, who underwent 
aortic valve replacement between June 1971 and December 1992. Two 
hundred six patients (64%) have had surgery since the end of 1985. Their 
mean age was 82.7 years (range 80 to 92 years). One hundred seventy-one 
(53%) were male and most (86%) were in New York Heart Association class 
III-IV. Fifty-seven patients (18%) required admission to the coronary care 
unit before the operation. One hundred seventy-nine patients (56%) 
underwent an urgent or emergency operation. Known cerebrovascular 
disease was present in 77 (24% of patients), aortic stenosis in 79%, aortic 
incompetence in 9%, and combined stenosis and incompetence in 12%. 
Associated procedures included bypass grafting in 139 (43%), mitral valve 
replacement/repair in 20 (6%), tricuspid valve repair in 6 (2%), and aortic 
annular enlargement in 38 (12%). Thirty patients (9.3%) were undergoing 
reoperation. Hospital mortality was 44 of 322 (13.7%). The median hospital 
stay was 11 days. On univariate analysis, significant predictors of hospital 
mortality were female sex, preoperative rest pain, New York Heart Associ- 
ation class III-IV, admission to the coronary care unit, heart failure, mitral 
valve disease, emergency/urgent operation, chronic obstructive pulmonary 
disease, bypass grafting, valve size, peripheral vascular disease, and 
ejection fraction less than 0.35. On multivariate analysis the most impor- 
tant independent predictors of operative mortality were female gender (p = 
0.0001), renal impairment (p = 0.001), bypass grafting (p = 0.005), ejection 
fraction less than 0.35 (p = 0.01), and chronic obstructive pulmonary 
disease (p = 0.028). Age and year of operation did not influence mortality. 
Five-year survivals for all patients and for operative survivors were 60.2% 
-+ 3.2% and 70.3% - 3.4%, respectively. On univariate analysis, factors that 
adversely affected long-term survival were coronary bypass grafting (p = 
0.007), more than two comorbidities (p = 0.02), male gender (p = 0.04), and 
ejection fraction less than 0.35 (p = 0.04). On multivariate analysis, no 
factor was consistently significant for long.term survival. At most recent 
clinical follow-up 85% were angina free and 82% were in class I-II. At least 
92% of patients, both at 1 year and at most recent clinical follow-up, 
believed they had significantly benefited from the operation: Conclusion: 
Risk factors for aortic valve replacement in octogenarians include female 
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gender, unstable symptoms, poor ejection fraction, renal impairment, and 
bypass grafting. However, despite a hospital mortality higher than that 
reported for younger patients, the outlook for operative survivors is 
excellent, with good relief of symptoms and an expected survival normal for 
this particular age group. If possible, aortic valve replacement should be 
done before development of unstable symptoms. (J Thorac Cardiovasc Surg 
1996;111:1026-36) 
A ccording to the U.S. Bureau of Statistics, in 1995 the number of Americans aged 75 years or older 
was 14.5 million and by the year 2005 this figure is 
expected to rise to 17.1 million. 1 Thus elderly per- 
sons constitute 6% of the population, and at least 
46% are thought to have symptomatic cardiac dis- 
ease. 2 With this aging of the population and the 
greater use of noninvasive diagnostic techniques, 
particularly echocardiography with two-dimensional 
Doppler ultrasonography, the diagnosis of symp- 
tomatic aortic valve disease, particularly aortic ste- 
nosis, is becoming increasingly common. Although 
aortic valve replacement (AVR) has a higher risk in 
older patients, AVR is the only effective treatment 
for symptomatic aortic stenosis. Age alone is not a 
contraindication for this operation, inasmuch as 
several studies have shown that AVR in patients 80 
years or older can be performed with an acceptable 
operative mortality and morbidity. 3q2 However, the 
long-term outcome in these patients has not been 
documented. To analyze these issues further, we 
have reviewed our early and long-term results in 
patients aged 80 years and older who have under- 
gone AVR at the Mayo Medical Center, Rochester, 
Minnesota, between June 1971 and December 1992. 
Methods 
Records of 322 patients who underwent AVR, with or 
without concomitant procedures, were reviewed. A total 
of 84 preoperative, operative, and postoperative ariables 
were recorded. Follow-up information was obtained from 
all hospital survivors through clinic visits and annual 
letters. Between May and July 1994 all known survivors 
were sent a letter questionnaire. This was designed to 
determine general health status, presence or absence of 
chest pain, dyspnea or angina pectoris, postoperative N w 
York Heart Association (NYHA) functional class, the 
overall effects of the operation, and quality of life. Any 
subsequent reoperation was also recorded. Question- 
naires were also sent to the patient's local physician. 
Coronary artery disease was defined as a reduction of 
vessel diameter by at least 50% in one view on coronary 
angiography. Stenosis to this degree in the left anterior 
descending system, circumflex system, or right coronary 
system was used for the criterion of single, double, or 
triple vessel disease. Stenosis of 50% or more in the left 
main coronary artery was described as double vessel 
disease in the absence of other coronary stenoses. Oper- 
ative mortality was any death occurring within 30 days of 
the operation or death during the same hospital admission 
as the operation. Renal impairment was defined as a 
serum creatinine concentration of 1.5 mg/dl or more. 
Heart failure was determined by the presence of pulmo- 
nary congestion or opacities consistent with edema on 
chest roentgenograms. 
Distribution for all relevant variables has been ex- 
pressed either as percentages or as mean +- standard 
deviation. The effects of nominal risk factors, such as 
presence of rest pain, on early mortality were evaluated 
univariately with )(2 tests or Fisher's exact est. The effects 
of continuous variables, such as age and serum creatinine 
concentration, were univariately evaluated with two-sam- 
ple t tests or with Wilcoxon rank sum tests when neces- 
sary. Combinations of risk factors were multivariately 
evaluated with multiple logistic regression models. Survi- 
vorship to death, for all patients and for all hospital 
survivors, was estimated by means of the Kaplan-Meier 
method. To assess eparately those risk factors related to 
late survival as distinct from operative deaths, we analyzed 
only hospital survivors. Nominal risk factors for survival 
were assessed with log-rank tests. Continuous measurable 
risk factors, such as age, and combinations of risk factors, 
both nominal and continuous, were evaluated with Cox's 
proportional hazards models. A p value <0.05 was con- 
sidered statistically significant. 
Results 
The study comprised 171 men (53%) and 151 
women. Their mean age was 82.7 years (range 80 to 
92 years). The majority of patients have undergone 
surgery since 1986. The distribution of patients 
undergoing surgery during three different ime pe- 
riods was as follows: 16 (5%) in 1971 to 1977, 100 
(31%) in 1978 to 1985; and 206 (64%) in 1986 to 
1992. 
Symptoms included dyspnea (310, 96%), angina 
pectoris (134, 42%), and syncope (88, 27%). A 
diagnosis of heart failure was made in 197 (61%) 
patients. A total of 276 (86%) patients were consid- 
ered to be in NYHA class Il l-IV. Only seven 
patients had no or minimal symptoms. Two hundred 
fifty-four (79%) patients were considered to have 
aortic stenosis, 28 (9%) had mixed aortic stenosis 
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Table I. Preoperative comorbidities in 322 patients 
aged 80 years or older undergoing A FR 
n % 
Hypertension 163 51 
Previous myocardial infarction 48 15 
Diabetes mellitus 35 11 
Renal impairment* 75 23 
Cerebrovascular disease 77 24 
Asymptomatic 26 
TIA 17 
CVA 28 
CEA 2 
CEA/CVA 4 
Chronic obstructive airway disease 65 20 
Peripheral vascular disease 37 12 
Abdominal aortic aneurysm 22 7 
T/A, temporary ischemic accident; CVA, cerebrovascular accident; CEA, 
carotid endarterectomy. 
*Creatinine concentration ->1.5 mg/dl 
and regurgitation, and 39 (12%) had aortic insuffi- 
ciency. Preoperative comorbidities are listed in Ta- 
ble I. Seventy-seven (24%) patients had known 
cerebrovascular disease. Of these, 34 (11%) had had 
cerebrovascular accidents or had undergone carotid 
endarterectomy (or both). Twenty-two (7%) of the 
patients had known or resected abdominal aneu- 
rysms. One hundred forty-three (44%) patients had 
an elective operation, 163 (51%) had an urgent 
operation because of angina or heart failure that did 
not respond to the usual clinical measures, and 16 
(5%) patients required an emergency operation for 
hemodynamic deterioration. Only one patient re- 
quired an intraaortic balloon pump before the op- 
eration. Men and women differed significantly with 
regard to certain clinical features (Table II). 
Whereas men were more likely to have coronary 
artery disease, a history of myocardial infarction, 
renal impairment, and a need for coronary artery 
bypass grafting (CABG), women tended to have 
heart failure and required smaller prostheses. 
Women were also more likely to reside in the local 
community. 
Hemodynamic and augiographic studies. Preop- 
erative cardiac atheterization was performed in 180 
(56%) patients and echocardiography in 220 (68%). 
We do not perform invasive hemodynamic studies of 
the valve if clinical symptoms, physical examination, 
and two-dimensional echocardiography are all indic- 
ative of aortic valve disease. 13 A summary of the 
hemodynamic data is listed in Table III. Three 
hundred (93%) patients had an estimate of left 
ventricular ejection fraction by either left ventricu- 
lography or echocardiography. Of these, 64 (21%) 
had an ejection fraction of less than 0.35. Coronary 
angiography was performed in 295 (92%) patients. 
Significant coronary artery disease was present in 
173 (59%) of these patients. Sixty-eight had single 
vessel disease, 40 had two vessel disease, and 65 had 
three vessel disease. Twenty-two patients had left 
main disease. 
Previous operation. Thirty patients (9%) had un- 
dergone a previous cardiac operation 77 _+ 42.6 
months earlier (Table IV). Of these, 21 had AVR or 
decalcification of the valve. A further 10 patients 
underwent percutaneous balloon valvuloplasty 14 _+ 
17.0 months before the definitive aortic valve oper- 
ation. 
Operation. All patients underwent AVR. In ad- 
dition, 139 (43%) patients had concomitant CABG, 
the left internal thoracic artery being used in 39 
(28%) instances. In 38 (11.8%) patients the aortic 
anulus was enlarged with a perieardial patch. Other 
procedures are listed in Table V. The majority of 
patients (287, 89%) received either a porcine or 
pericardial bioprosthesis. Three patients received a
homograft, and 32 (10%) patients had a mechanical 
prosthesis. 
Perioperative mortality. Death occurred in 44 
patients (13.7%) (Table VI). Causes of death were 
as follows: low cardiac output or myocardial infarc- 
tion, or both, 21; multiorgan failure, 11; respiratory 
failure, 4; sepsis, 2; renal failure, 1; cerebrovascular 
accident, 4; and sudden unexpected eath, 1. On 
univariate analysis, female gender, rest pain, ad- 
vanced NYHA class, heart failure, urgency of the 
operation, mitral valve disease, ejection fraction less 
than 0.35, admission to the coronary care unit, renal 
impairment, chronic obstructive pulmonary disease, 
peripheral vascular disease, more than two comor- 
bidities, CABG, and valve size were important de- 
terminants of hospital mortality. However, on mul- 
tivariate analysis, female gender (p = 0.0001), renal 
impairment (p = 0.001), CABG (p = 0.005), ejec- 
tion fraction less than 0.35 (p = 0.01), and chronic 
obstructive pulmonary disease (p = 0.028) remained 
significantly related to hospital death. Age, year of 
operation, myocardial infarction, reoperative sur- 
gery, diabetes, coexistence of cerebrovascular dis- 
ease, and distance traveled to the Mayo Clinic, 
which is a measure of referral bias, were not related 
to hospital mortality. Although patients with coro- 
nary artery disease had a higher mortality than those 
without coronary artery disease, this difference was 
not statistically significant. 
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Table II. Gender differences in 322 patients aged >80 years or older undergoing AVR 
Male Female 
n % n % p Value 
Coronary artery disease* 107 67 66 49 0.001 
Myocardial infarction 31 18 17 11 0.08 
Renal impairment 66 39 31 21 0.001 
CABG 87 51 52 34 0.003 
Heart failure 97 57 100 66 0.08 
Residence >60 miles from Mayo Clinic 130 77 85 56 0.001 
Valve size <23 mm 30 18 113 75 0.001 
*A total of 295 patients underwent coronary angiography. 
Table III. Hernodynamic data & 322 patients aged 
80 years or older undergoing AVR 
Table IV. Previous operations in 30 of 322 patients 
aged 80 years or older undergoing AVR 
EF, ejection fraction; Echo, echocardiography; Cath, catheterization; 
LVEDP, left ventricular end-diastolic pressure; AVA, aortic valve area. 
*Ejection fraction was estimated by echocardiography and/or left ventricu- 
lography in 300 patients. 
?Patients with aortic stenosis or mixed aortic stenosis and regurgitation. 
n Mean +_ SD AVR 5 
EF* AVR + CABG 6 
Echo 220 50.4% _+ 16.5% AVR + MVR i 
Cath 128 52.6% _+ 13.7% AV decalcification 1 
EF <35% (echo or cath) 64 (21%) AV decalcification + CABG 8 
LVEDP 180 27.0 _+ 8.8 mm Hg MVR 2 
Mean gradient? CABG 7 
Echo 153 57.8 _+ 20.3 mm Hg AVR, Aortic valve replacement; CABG, coronary artery bypass grafting; 
Cath 172 59.5 -+ 25.5 mm Hg MVR, mitrai valve replacement; AV, aortic valve. 
AVA? 
Echo 146 0.6 -+ 0.2 cm 2 
Cath 141 0.5 _+ 0.2 cm 2 Table V. Operative procedures in 322 patients aged 
80 years or older undergoing A VR 
Postoperative morbidity. The median stay in the 
hospital after the operation was 11 days. Twenty-one 
patients (7%) had hospital stays of more than 30 days. 
Significant postoperative complications, apart from 
atrial arrhythmias, occurred in 172 (53%) patients. 
These complications are listed in Table VII. Twenty- 
seven patients (8.4%)had a cerebrovascular accident. 
Of these, eight recovered completely, five were left 
with residual defects, and 14 died. Of these 14 deaths, 
four were thought o be directly related to the stroke. 
The presence of diabetes, known cerebrovascular dis- 
ease, peripheral vascular disease, or a preoperative 
abdominal aneurysm was not related to the develop- 
ment of a postoperative stroke. 
Long-term results. The mean follow-up time was 
46 months, the longest being 15.4 years. Among the 
278 hospital survivors, there have been 120 subse- 
quent deaths. Four patients (1.4%) have been lost to 
follow-up since discharge from the hospital. A fur- 
ther six patients have had follow-up for less than 1 
year. 
AVR 162 
AVR + CABG 136 
AVR + MVR 8 
AVR + MVR + CABG 2 
AVR + MVR + tricuspid annuloplasty 4 
AVR + MV repair + CABG 1 
AVR + MV repair + tricuspid annuloplasty 1 
AVR + MV repair 4 
AVR + tricuspid annuloplasty 1 
AVR + pericardectomy 1 
AVR + replacement of ascending aorta and arch 1 
AVR + LV apex-innominate artery conduit 1 
Aortic annular enlargement 38 (11.8%) 
Septal myectomy 8 
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting; 
MV,, mitraI valve; MVR, mitral valve replacement; LV, left ventricle. 
The 1- and 5-year survivals (+ standard error of 
the mean) of all patients were 83.3% _+ 2.1% and 
60.2% _+ 3.2%, respectively. For operative survivors, 
the corresponding survivals were 96.7% _+ 1.1% and 
70.3% _+ 3.4%, respectively (Fig. 1). The 5-year 
mortality of a population matched for age and sex is 
59.0% _+ 3.4% (p = 0.057). On univariate analysis, 
the following factors were significantly related to the 
long-term survival of those patients who left the 
hospital: gender (male: 5 years, 66.3% _+ 4.6%; 
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Tab le  VI .  Operative mortality in 322 patients aged 80 years or older undergoing AVR 
Mortality Initial probability Final probability 
Clinical features n n % X e p X 2 p 
Male 171 16 9.4 
Female 151 28 18.5 5.7 0.02 15.5 0.0001 
Year of operation 
1971-1985 116 16 13.8 
1986-1991 206 28 13.6 0.02 NS 
NYHA class I-H 46 1 2.2 
NYHA class III-IV 276 43 15.6 6.0 0.01 
Rest pain 
No 291 33 11.3 
Yes 31 11 35.5 13.8 0.001 
CCU 
No 265 26 9.8 
Yes 57 18 31.6 18.8 0.001 
Heart failure 
No 125 10 8.0 
Yes 197 34 17.3 5.6 0.02 
Mitral valve disease 
No 277 32 11.6 
Yes 45 12 26.7 7.5 0.006 
EF <0.35 
No 236 23 9.8 
Yes 64 16 25.0 10.4 0.001 6.3 0.012 
MI 
No 274 34 12.4 
Yes 48 10 20.8 2.5 NS 
CAD 
No 122 12 9.8 
Yes 173 29 16.8 2.9 NS 
CABG 
No 183 19 10.4 
Yes 139 25 18.0 3.9 0.05 8.0 0.005 
Reoperation 
No 292 38 13.0 
Yes 30 6 20.0 1.1 NS 
Urgent operation 
No 143 8 5.6 
Yes 179 36 20.1 14.2 0.001 
Creatinine ->1.5 mg/dl 
No 225 21 9.3 
Yes 97 23 23.7 11.9 0.001 10.6 0.001 
Diabetes 
No 287 36 12.5 
Yes 35 8 22.9 2.8 NS 
PVD 
No 285 33 11.6 
Yes 37 11 29.7 9.1 0.002 
COPD 
No 257 30 11.7 
Yes 65 14 21.5 4.3 0.04 4.9 0.028 
CVD 
No 245 31 12.7 
Yes 77 13 i6.9 0.9 NS 
More than two comorbidities 
No 193 17 8.8 
Yes 129 27 20.9 9.6 0.002 
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Table VI. Continued 
Mortality Initial probability Final probability 
Clinical features n n % X e p X e p 
More than 60 miles from clinic 
No 105 18 17.1 
Yes 215 26 12.1 1.5 NS 
Valve size (mm) 
<20 39 9 23.1 
21 + 22 104 17 16.4 
23 128 15 11.7 
25 + 27 48 2 4.2 7.72 0.05 
NYHA, New York Heart Association; CCU, coronary care unit; EF, ejection fraction; M/, myocardial infarction; CAD, coronary artery disease; CABG, coronary 
artery bypass grafting; PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease, NS, not significant. 
female: 5 years, 75.7% _+ 4.8%; p = 0.04), CABG 
(p = 0.007), presence of more than two comorbidi- 
ties (p = 0.02), and ejection fraction less than 0.35 
(p = 0.04) (Figs. 2 to 5). No difference in survival 
was noted between patients 82 years old or less and 
those older than 82 years. When the aforemen- 
tioned significant factors were entered into a Cox 
regression analysis, it was not possible to derive a 
consistent multivariate model to predict risk factors 
influencing survival. 
Quality of life. Information regarding the 1-year 
clinical status was available in 255 of the 278 hospi- 
tal sUrvivors. Two hundred thirty-six patients (93%) 
reported no angina. One hundred fifteen (45%) still 
had some dyspnea. Only six patients (3%) were 
considered to be in NYHA class III-IV. However, 
this improvement did not persist. At the most recent 
clinical follow-up examination (mean of 47 months), 
47 patients (18%) were considered to be in NYHA 
class Ill-IV. Of the 254 patients who responded to 
the question as to whether they had benefited from 
the operation, 5% thought that their condition was 
unchanged, 3% thought hat they were in worse 
condition, and 92% thought that they were in better 
condition. 
Three patients had another cardiac operation. Two 
operations were for perivalvular regurgitation a d the 
third for a leaflet perforation of a previously placed 
Carpentier-Edwards porcine bioprosthesis (Baxter 
Healthcare Corp., Edwards Div., Santa Ana, Calif.). 
Discussion 
With the aging of the population, elderly patients 
are being increasingly referred to and being ac- 
cepted by the cardiac surgeon for the surgical man- 
agement of aortic stenosis. This trend has also been 
accentuated bythe broader use of two-dimensional 
echocardiography with Doppler ultrasonography 13 
Table VII. Postoperative complications in 322 
patients aged 80 years or older undergoing A VR 
Complications n % 
Low cardiac output 75 23 
Postoperative LM3P 18 6 
Prolonged ventilation (>72 hr) 56 17 
Reexploration for bleeding 15 5 
Cerebrovascular ccident 27 8 
Permanent pacemaker 35 11 
Renal failure 18 6 
Mediastinitis 2 1 
IABP, Intraaortic balloon pump. 
for the noninvasive valuation of valvular heart 
disease and by the greater willingness of referring 
cardiologists oexamine lderly patients with angina 
primarily with a view to myocardial revasculariza- 
tion. Although 43% Of our patients underwent com- 
bined AVR and CABG, we do not have information 
on how many were primarily evaluated for myocar- 
dial ischemia and were found to have incidental 
aortic stenosis. In previous tudies we 24 have shown 
that patients undergoing combined AVR and 
CABG have lesser degrees of aortic stenosis than 
those with isolated aortic stenosis. 
AVR remains the only effective treatment for 
aortic stenosis. Previous studies of natural history 
have shown a poor outcome for patients with severe 
aortic stenosis who were treated medicallyJ 5'26 Al- 
though some hoped that percutaneous balloon val- 
vuloplasty would be a successful treatment for aortic 
stenosis in elderly patients, both the medium- and 
long-term results of this therapy have been ex- 
tremely disappointing. Symptoms have recurred 
within 1 year of treatment inmost patients and have 
necessitated subsequent surgery. 17' 28 Aortic balloon 
valvuloplasty is no longer covered by Medicare. In 
addition, aortic valve decalcification has not been 
100 
Gehlot et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
May 1996 
" -%.  
"'~"'" 
8O 
g 
60 ¸  
._> 
~> 40 "~ 
CO 
20. 
0 
0 
n= 
1032 
259 217 167 132 98 67 53 36 23 16 
Years 
Fig. 1. Survival curve of all 322 patients and 278 hospital 
survivors aged 80 years and older undergoing AVR. 
100 q 
80-  
60 -  
"~ 40 - 
ffl 
20- 
o 
'~~~ P=0.007 
-,- Avn ~" ' ; "~" i~ 
"O- AVR + CABG 
Years 
AVR 164 156 130 105 85 68 50 41 28 23 16 
AVR + CABG 114 104 87 62 48 31 16 12 8 
Fig. 3. Effect of CABG on survival in 278 hospital survi- 
vors aged 80 years and older undergoing AVR. Number at 
risk shown by year. 
._> 
u) 
100 
80- 
60" 
40- 
20" 
0 
-o -  Males ~.  -"~ 
-O-  Females ~-~ 
Years 
Males 155 144 118 91 72 53 33 24 16 11 7 
Females 123 115 100 76 61 46 34 29 20 12 9 
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vors aged 80 years and older undergoing AVR. Number at 
risk shown by year. 
effective in the long term, with many patients return- 
ing for further surgery for either recurrent aortic 
stenosis or significant aortic regurgitation. 19 
We believe that most elderly patients with signifi- 
cant symptomatic aortic stenosis are candidates for 
AVR. Clearly comorbid isease, such as renal impair- 
ment and chronic obstructive pulmonary disease, in- 
creases operative risk. However, we do not have any 
information on how many patients were turned down 
for, or declined, surgery. Serious life-threatening ill-
ness such as disseminated malignant disease, severe 
disability from a cerebrovascular accident, or marked 
infirmity would be contraindications for surgery. In 
these elderly patients, the decision to operate needs to 
be individualized, with the patient and family aware of 
the risks and benefits of the operation. Our results 
dearly show that the majority of patients do well, with 
the 5-year survival far better than that for untreated 
symptomatic aortic stenosis. 
A less common but more controversial problem is 
the management of significant aortic stenosis in the 
patient who has no symptoms. In such circumstances 
the risk of sudden death as the first clinical mani- 
festation of aortic stenosis is rare. z° Again, treat- 
ment decisions need to be individualized, but most 
patients without symptoms can be observed unless 
the aortic stenosis is severe nough to be of concern. 
A patient with an aortic valve area less than 0.7 cmz 
needs to be seriously considered for surgery, even if 
free of symptoms. 
Patients in whom coronary artery disease is the 
primary problem may have mild aortic stenosis, 
which by itself would not necessarily warrant an 
operation. The decision whether to replace the 
aortic valve in such circumstances is difficult. How- 
ever, we believe that the surgeon should favor AVR, 
particularly inasmuch as AVR after previous CABG 
carries a substantial mortality. In a recent review of 
our own experience, the operative mortality for 
AVR after previous CABG was 16.2%.* 
Several points in the operative technique for 
AVR in elderly patients need emphasis. The cardiac 
tissues are often friable and careful handling of the 
heart during all aspects of the operation is essential. 
The small aortic root, particularly in the female 
patient, may need to be enlarged to accommodate a 
valve of adequate size. In most instances we would 
avoid placement of a 19 mm tissue valve and instead 
enlarge the aortic root with a pericardial patch. 2a' 22 
Not only does this allow placement of a valve one 
size larger, but it may also facilitate placement of the 
*Odell JA, Mullany CJ, Schaff HV, Orszulak TA, Morris JJ. 
Aortic valve replacement after previous coronary artery by- 
pass grafting. Unpublished ata. 
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hospital survivors aged 80 years and older undergoing 
AVR. Number at risk shown by year. 
valve, including closure of the aortic root. Most 
patients hould receive a tissue valve inasmuch as 
the long-term durability of such valves in this age 
group is excellent and the need for long-term anti- 
coagulation is avoided. If the patient requires mul- 
tiple coronary artery grafts, use of the internal 
thoracic artery is helpful because this avoids an 
additional aortic anastomosis. 
The overall operative mortality in this series is 
comparable with those already reported in other 
series (4.2%1°; 9.4%6; 12.7%4; 17.5%3; and 28%5). 
The most important factors related to mortality, 
apart from gender, appear to be related to severity 
of symptoms, urgency of the operation, ejection 
fraction, and coexisting disease such as renal impair- 
ment. Patients in NYHA class I-II had the lowest 
mortality (2.2%) and patients admitted to the hos- 
pital for elective surgery had a mortality of 5.6%. 
These observations suggest that surgery, if possible, 
should be undertaken before the development of 
unstable symptoms or heart failure necessitating 
urgent admission to the hospital. Once a decision 
has been made to proceed, the operation should be 
undertaken without undue delay. The higher mor- 
tality in women has been noted previously. 23'24 
Recent data from our own institution also demon- 
strated the importance of female gender in mortal- 
ity. 24 However, the cause of this excessive mortality 
is not clear, particularly inasmuch as coronary artery 
disease, prior myocardial infarction, and renal dis- 
ease are less prevalent in women than men. Small 
valve size (<23 mm) may be important, because this 
is far more prevalent in women. Patients receiving 
small valves had a significantly higher mortality than 
those receiving valves larger than 23 mm. 
Cerebrovascular ccidents continue to be impor- 
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hospital survivors aged 80 years and older undergoing 
AVR. Number at risk shown by year. 
tant complications of surgery in this age group. 
However, we found no correlation between these 
events and a history of cerebrovascular or peripheral 
vascular disease. Others have shown that aortic 
calcification, older age, perioperative hypotension, 
and prolonged bypass time are important determi- 
nants of perioperative strokes, z5 Inasmuch as most 
cerebral events are thought o be embolic, careful 
aortic cannulation, removal of loose calcific debris in 
the aorta, removal of air, and minimal reclamping of 
the aorta should be important aspects of the oper- 
ation in this age group. Maintenance of adequate 
perfusion pressur e during cardiopulmonary b pass 
(>60 mm Hg), particularly in patients with known 
cerebrovascular disease, is most probably important. 
The role of systemic hypothermia versus normother- 
mic perfusion remains a subject of controversy, z6'27 
However, recent data suggest hat systemic hypo- 
thermia is likely to be more cerebroprotective than 
normothermia. 26 
Whether to perform CABG at the same time as 
AVR is a question that many investigators have 
attempted to address. 14' 28 In this series, 34 patients 
had coronary artery disease that was not grafted, 
and four of them died (11.8%). Although the mor- 
tality of patients undergoing CABG was significantly 
greater than that for those who did not have CABG, 
we believe that coronary arteries with significant 
stenoses hould be grafted if possible. An earlier 
study from our own institution has shown that 
patients who have unrecognized and ungrafted cor- 
onary artery disease at the time of AVR may be at 
significant risk for a perioperative myocardial infarc- 
tion or death. 14 Although in that early series a 
significant number of patients did not undergo 
preoperative coronary angiography, particularly in 
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the absence of angina, 14 we now believe that angiog- 
raphy should be undertaken in all patients. How- 
ever, invasive assessment of the valve is not essential 
if the clinical symptoms, physical examination, and 
results of two-dimensional echocardiography are all 
indicative of significant aortic valve disease, t3 
The long-term results of AVR are clearly better 
than the results of untreated aortic stenosis. The 
long-term survival, which is equivalent at least to 
that of an age- and sex-matched population, proba- 
bly indicates in part a process by which both cardi- 
ologists and surgeons have selected suitable candi- 
dates for surgery. The improvement in quality of life 
further emphasizes the value of surgical treatment 
in this particular age group. We believe that success- 
ful treatment probably results in fewer subsequent 
admissions to the hospital for repeated management 
of heart failure or angina. This is likely to result in 
significant cost savings, particularly in an era of 
increasing scarcity of health care dollars. 
We acknowledge contributions to patient care by Dr. 
Gordon Danielson, Dr. Francisco Puga, Dr. Christopher 
McGregor, Dr. Jeffrey Piehler, Dr. James Pluth, and Dr. 
R. Michael King and careful typing of the manuscript by 
Kathy Distad. 
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Discussion 
Dr. Aurelio Chaux (Los Angeles, C~lif). Given the fast 
growth of the population 80 years and older, it is impor- 
tant to continue to collect information regarding the 
results of cardiac surgery and the determinants of out- 
comes in this group. In this review, the authors have 
reiterated that acute symptoms uch as rest pain indicate 
that surgery should be performed on an urgent or emer- 
gency basis. They also reiterate that female gender, low 
ejection fraction, renal impairment, and the presence of 
mitral valve disease are important predictors of operative 
mortality. The hospital mortality of 13.7% reported by the 
authors is three times higher than the mortality reported 
last year by our group, and female gender was very 
significant in their series. This leads me to my first 
question. Do you think that the frequent use of aortic root 
enlargement, particularly in women, has some effect on 
this mortality? We rarely use this operation and would 
prefer, if there is no contraindication to warfarin sodium, 
to implant a mechanical prosthesis. I noticed a correla- 
tion, not only with female gender, but also with small size 
valve. Can you provide more information regarding the 
results in this subgroup of patients in which aortic root 
enlargement was performed. 
Dr. Gehlot. At the Mayo Clinic there is a low threshold 
for doing aortic annular enlargement with a pericardial 
patch. Thirty-eight patients required aortic annular en- 
largement so that a larger size valve could be inserted. In 
addition, enlargement of the aortic root makes it easier to 
close the aortotomy. Of 38 patients who had annular 
enlargement, six died. 
Dr. Chanx. One of the important contributions of this 
review is to provide information regarding the long-term 
outcomes. Your mean follow-up is a very respectable 46 
months. In the univariate analysis, factors that adversely 
affected the long-term survival were male sex, concomi- 
tant CABG, presence of two comorbidities, and low 
ejection fraction. I was surprised by the fact that in a 
multivariate analysis none of the factors remained signif- 
icant according to your manuscript. I wonder if the reason 
for this is that when you performed the multivariate 
analysis, you tested only those that were statistically 
significant and not all of the factors that were analyzed in 
the univariate analysis. 
Dr. Gehlot. All the factors that were significant on 
univariate analysis for long-term survival were entered 
into the Cox regression analysis. By entering them into a 
forward or backward model, we found a different factor 
that came up significant in each model. Therefore, none of 
the factors was consistently significant on multivariate 
analysis. 
Dr. Chaux. I think to do the multivariate analysis you 
should include all of the factors, not just the ones that 
were significant in the univariate analysis. We have always 
found, for instance, that age continues to be a significant 
factor that influences the long-term results of the patient. 
In the manuscript you state that only 56% of patients 
have preoperative cardiac catheterization. Do you mean 
that only 56% had invasive hemodynamic evaluation? If
so, did all patients have preoperative coronary angiogra- 
phy? 
Dr. Gehlot. Of the 322 patients, 300 patients had an 
estimate of their left ventricular ejection fraction by 
cardiac catheterization or echocardiography or both. 
There were 221 patients who had an echocardiogram and 
there were 172 patients who had cardiac catheterization 
with left ventriculography. 
Dr. Chaux. Did all patients have coronary angiography? 
Dr. Gehlot. I believe that there were a few patients 
during the early years of our experience who did not have 
coronary angiography. 
Dr. Chaux. How can you estimate the incidence of 
coronary artery disease in this population if you do not 
know preoperatively what the coronary anatomy is? 
Dr. Gehlot. The great majority of the patients had 
coronary angiography before the operation. 
Dr, Chaux. Do you agree that there are three different 
types of patient populations that should be analyzed 
separately, namely, those with isolated aortic valve dis- 
ease, those with primarily aortic valve disease and inci- 
dental coronary artery disease, and those with primarily 
coronary artery disease and incidental findings of aortic 
valve disease? In our experience, if we analyze the results 
in this way, these results are entirely different. 
Dr. Gehlot. You are correct. The paper we have pre- 
sented considers anyone who has had an AVR, including 
those with coexisting coronary artery disease or mitral 
valve disease. However, we do not have information on 
which patients were primarily investigated for coronary 
artery disease and found to have incidental aortic valve 
disease. Valve mortality for isolated AVR was approxi- 
mately 8%. 
Dr. Chaux. Finally, the survival curves that you have 
presented eliminated the hospital mortality. Don't you 
think that, in trying to determine survival in this patient 
population, this is an important factor that should be 
included in the analysis? I think that it is misleading to 
eliminate hospital mortality from consideration when 
advising our elderly patients as to whether they should 
have an operation or not. Do you agree or disagree? 
Dr. Gehlot. When we are discussing the operation with 
a patient, he or she is interested in what the surgical risk 
is. If the operation is successful, we are able to explain to 
the patient what the long-term outlook is expected to be. 
This is why we have presented the data in this fashion. 
Dr. Chaux. If you are going to do that, you have to be 
very clear and explicit about the reasons why you elimi- 
nated the hospital mortality from the analysis. 
Dr. John V. Redington (Torrance, Calif.). Dr. Gehlot, 
have you addressed the issue of extensive ascending aortic 
atherosclerosis? We are seeing this comorbidity more 
frequently in this patient population. It has forced me to 
do AVR with deep hypothermia nd circulatory arrest 
with retrograde cerebral perfusion. Do you have a sub- 
population with extensive ascending atherosclerosis? 
What has your strategy been in handling that phenome- 
non in the octogenarian population? 
Dr. Gehlot. We did not specifically evaluate aortic 
atherosclerosis a a comorbid factor. However, we did 
attempt o see what risk factors were present in the 27 
patients who had a postoperative cerebrovascular cci- 
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dent. Diabetes, peripheral vascular disease, known preop- 
erative cerebrovascular disease, and preoperative abdom- 
inal aneurysm did not have any relationship to the 
development of postoperative stroke. 
Dr. Redington. Have you used deep hypothermia nd 
circulatory arrest in any octogenarian patients with pro- 
found ascending aortic atherosclerosis? 
Dr. Gehlot. There were one or two patients who had 
surgery with deep hypothermia nd total circulatory ar- 
rest. 
Dr. Redington. Your impression, then, is that at least 
aortic embolic events have not been an identifiable cause 
of cerebrovascular accidents in your population. 
Dr. Gehlot. In general, most cerebrovascular events 
after cardiac surgery are thought o be embolic in nature. 
We believe careful handling of the tissues, including aortic 
cannulation, removal of all calcific debris, and evacuation 
of air at the completion of the procedure are important 
aspects of the operation. 
Dr. Redington. That is rather the point of my question. 
One would have to suspect that atheroembolic events 
from the ascending aorta in this population would be a 
substantial contributor to cerebrovascular ccidents and 
therefore morbidity and mortality. 
Dr. Gehlot. You are correct that aortic atheroemboli 
are believed to be an important cause of perioperative 
stroke. This is a large series over many years and we do 
not have enough information about the state of the aorta 
in all of these patients. 
Dr. R. Scott Mitchell (Stanford, Calif.). Dr. Stinson at 
our institution looked at a similar cohort of elderly 
patients and saw also that the extent of age was signifi- 
cantly ameliorated by comorbidities. One of the comor- 
bidities that was very significant was obstructive pulmo- 
nary disease, which did not achieve significance in your 
paper. Can you comment about that difference? Our 
patients with chronic obstructive pulmonary disease, renal 
insufficiency, and decreased ejection fractions all had 
significant increases in operative mortality. You did not 
find that in your patients. 
Dr. Gehlot. Patients with chronic obstructive pulmonary 
disease had a mortality of 21.5% compared with 11.7% for 
those without this disease. However, on multivariate 
analysis this was not significant, 
Dr. Mitchell. Do you have any information about the 
length of stay for this hospital cohort? 
Dr. Gehlot. The median length of stay in this population 
was 11 days. 
Dr. Colleen F. Sintek (Los Angeles, Calif.). I rise to offer 
an alternative to aortic root enlargement or to placement 
of a mechanical prosthesis n this age group of patients. At 
our institution for the past 21/2 years we have been using 
the stentless porcine aortic root supplied by Medtronic, 
Inc., the Freestyle valve. In this group of patients, we have 
found excellent hemodynamics in the small valve sizes, 
even sizes 19 and 21, with very low transvalvular g adients. 
We have used the freehand technique, leaving the non- 
coronary sinus portion of the Freestyle valve intact. The 
valve is fairly easy to insert, the technique is less demand- 
ing than an aortic root enlargement procedure, and one 
can use the retained noncoronary sinus portion of the 
Freestyle valve to augment that portion of the aortotomy 
or to reinforce it so that it does not bleed. 
Dr. Gehlot. We have used the stentless valve, but not in 
this age group. We do not believe that this is a device that 
should be used routinely for the small aortic root. 
